文献速递颈动脉与弓上血管

超声检出颈动脉狭窄患者的影像监测与医疗管理依从性不足

Inadequate Adherence to Imaging Surveillance and Medical Management in Patients with Duplex Ultrasound-Detected Carotid Artery Stenosis.
PubMed 文献 · Ann Vasc Surg · 2021-01-27

该回顾性研究分析2016至2017年单中心颈动脉双功超声数据,纳入340例≥50%颈动脉狭窄患者,发现54%有随访影像而46%无影像随访,无随访者他汀使用率更低(85% vs. 94%,P=0.01),且较少拥有医保或商业保险。

要点

  • 近半数超声检出≥50%颈动脉狭窄患者无影像随访。
  • 无影像随访者他汀使用率显著低于有随访者。
  • 血管外科医生开具超声检查与影像随访相关。

核心结论

  • 近半数超声检出≥50%颈动脉狭窄的患者无影像随访,且这些患者接受推荐他汀治疗的可能性更低。

研究设计与样本

  • 单中心回顾性分析2016至2017年所有颈动脉双功超声检查,纳入单侧或双侧≥50%颈动脉狭窄患者340例。

主要发现

  • 182例(54%)有随访影像,中位随访时间261天(IQR 166-366);158例(46%)无影像随访。
  • 无影像随访者与有随访者阿司匹林使用率(86% vs. 88%,P=0.6)和戒烟咨询率(71% vs. 71%,P=0.8)相似,但他汀使用率更低(85% vs. 94%,P=0.01)。
  • 有影像随访者后续颈动脉血运重建更常见(18% vs. 3%,P<0.001)。
  • 无影像随访者较少拥有Medicare或商业保险(54% vs. 75%,P<0.001)。
  • 在160例新发颈动脉狭窄亚组中,64%无影像随访,且他汀使用率更低(82% vs. 96%,P=0.007)。

关键数值与推荐

  • 多变量分析中,术前指征预测无影像随访(OR 8.1 [95%CI 2.5-26.4],P<0.001)。
  • 保护因素包括70-80%狭窄(OR 0.33 [95%CI 0.14-0.76],P=0.01)、血管外科医生开具检查(OR 0.40 [95%CI 0.19-0.83],P=0.01)及Medicare/商业保险(OR 0.36 [95%CI 0.2-0.66],P=0.001)。

临床怎么用

  • 对超声检出≥50%颈动脉狭窄患者,应确保影像监测和包括他汀在内的药物治疗依从性。
  • 血管外科医生参与开具检查可提高影像随访率。
  • 放弃影像监测需医患共同决策,但不免除药物治疗的必要性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is recommended that patients with ≥50% carotid artery stenosis undergo surveillance imaging and atherosclerotic risk reduction medical therapies, regardless of whether revascularization is performed. The objective of this study was to determine rates of adherence to these recommended measures and to identify risk factors for nonadherence. METHODS: A retrospective analysis was performed of all carotid duplex ultrasound (DUS) from 2016 to 2017 at a single institution. Patients with unilateral or bilateral ≥50% carotid stenosis were included. Primary outcomes were rates and timing of surveillance imaging and medication regimen. Patient and study characteristics were compared using univariate and multivariable analyses. A subgroup analysis of patients with a new finding of carotid stenosis was also performed. RESULTS: Carotid stenosis >50% was detected in 340 patients. Overall, 182 patients (54%) had follow-up imaging (median 261 days [IQR 166-366]) and 158 patients (46%) had no imaging follow-up (NIFU). NIFU patients had similar rates of aspirin use (86% vs. 88%, P = 0.6) and tobacco cessation counseling (71% vs. 71%, P = 0.8) but had less statin use (85% vs. 94%, P = 0.01) compared to those with imaging follow-up. Subsequent carotid revascularization was more common in patients with imaging follow-up (18% vs. 3%, P < 0.001). NIFU patients were less likely to have Medicare or commercial insurance (54% vs. 75%, P < 0.001). The indication for DUS in NIFU patients, compared to those in follow up, was less commonly neurologic symptoms (11% vs. 14%), more commonly other clinical findings (35% vs. 16%), and more commonly as work up before nonvascular surgery (25% vs. 4%, P < 0.001), respectively. NIFU rates decreased with increasing degree of carotid stenosis. Prior carotid intervention, prior DUS, or DUS ordered by a vascular surgeon were characteristics associated with imaging follow-up (P < 0.05 for all). In a subgroup of 160 patients with new carotid stenosis, a majority (64%) had NIFU and statin use was lower in these patients (82% vs. 96%, P = 0.007). On multivariable analysis, preop indication was predictive of NIFU (odds ratio [OR] 8.1 [95% confidence interval, CI 2.5-26.4], P < 0.001) whereas protective factors included: 70-80% stenosis (OR 0.33 [95% CI 0.14-0.76], P = 0.01), study ordered by vascular surgeon (OR 0.40 [95% CI 0.19-0.83], P = 0.01), and Medicare/commercial insurance (OR 0.36 [95% CI 0.2-0.66], P = 0.001). CONCLUSIONS: Nearly half of patients found to have ≥50% carotid stenosis on DUS had no imaging follow-up; these patients were less likely to be on recommended statin therapy. The benefits of nonrevascularization-based treatments for carotid disease require adherence to therapy. Forgoing surveillance imaging in patients with hemodynamically significant carotid stenosis should be a shared decision between provider and patient and does not obviate the need for medical therapies.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Boelitz K, Jirka C, Eberhardt RT, et al. Inadequate Adherence to Imaging Surveillance and Medical Management in Patients with Duplex Ultrasound-Detected Carotid Artery Stenosis. Ann Vasc Surg. 2021. PMID: 33508459. doi:10.1016/j.avsg.2020.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。